These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7549213)

  • 1. Clearance of gadolinium chelates by hemodialysis: an in vitro study.
    Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA
    J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme.
    Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D
    J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
    Puttagunta NR; Gibby WA; Smith GT
    Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.
    Gibby WA; Gibby KA; Gibby WA
    Invest Radiol; 2004 Mar; 39(3):138-42. PubMed ID: 15076005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies].
    Katagiri K; Okada S; Kumazaki T; Tsuboi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Nov; 58(13):739-44. PubMed ID: 9866990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.
    Kartamihardja AA; Nakajima T; Kameo S; Koyama H; Tsushima Y
    Br J Radiol; 2016 Oct; 89(1066):20160509. PubMed ID: 27459250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
    Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
    Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of gadolinium-DTPA by peritoneal dialysis.
    Dörsam J; Knopp MV; Schad L; Piesche S; Carl S; Oesingmann N
    Nephrol Dial Transplant; 1995; 10(7):1228-30. PubMed ID: 7478129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
    Runge VM
    J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of Gd-DTPA dialysis clearance rates by using a look-locker imaging technique.
    Niendorf ER; Santyr GE; Brazy PC; Grist TM
    Magn Reson Med; 1996 Oct; 36(4):571-8. PubMed ID: 8892210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
    Nilsson S
    Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry.
    Vander Elst L; Van Haverbeke Y; Goudemant JF; Muller RN
    Magn Reson Med; 1994 Apr; 31(4):437-44. PubMed ID: 8208120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study.
    Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T
    Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of Gd-DTPA by means of hemodialysis.
    Haustein J; Schuhmann-Giampieri G
    Eur J Radiol; 1990; 11(3):227-9. PubMed ID: 2265637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.